Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : BCAM International -- Ignore unavailable to you. Want to Upgrade?

To: N. Dixon who wrote (205)	5/28/1998 9:01:00 AM
From: Hope	Read Replies (1) \| Respond to of 333

BCAM International, Inc. and Textron Receive Funding From Major Manufacturer to Develop New Products Incorporating BCAM'S Body-Conforming Technology BCAM Receives First Royalty Check From Textron for Technology in Cadillac Seville Seats MELVILLE, N.Y., May 28 /PRNewswire/ -- BCAM International, Inc. (Nasdaq: BCAM - news), the developer of a revolutionary patented Intelligent Surface Technology (IST) and microvalve technology, announced today that a leading manufacturer outside the automotive industry is funding the development of products that will incorporate its proprietary technology. The Company said that the manufacturer has made a commitment to introduce the new products with BCAM International's patented Intelligent Surface Technology during 1998. Textron Automotive, a division of Textron, Inc. (NYSE: TXT - news), which has the exclusive license to use IST in the manufacturing and sale of seats and seating components for transportation, hospital beds, wheelchairs and office chairs, will develop the systems for these products. Michael Strauss, Chairman and Chief Executive Officer of BCAM International said, ''This commitment is the first commercial application using our proprietary technology outside of the automotive industry. These products will greatly increase the number of consumers who will discover the enormous benefits in comfort and fit when a product conforms to an individual's unique body imprint. We believe this is the first in a long list of applications that will incorporate this proprietary ergonomic technology.'' The Company also announced that it had received its first royalty check from Textron Automotive for sales of 1998 Cadillac Seville STS models that incorporated this technology into the driver and passenger seats. It is also expected that in 1999, IST technology will be introduced in several other 1999 automobile models. Strauss said, ''This is a major milestone for BCAM International. After heavy investment, many years of development and after receiving eight (8) patents for this technology, this is the first royalty check for the use of IST for any commercial product.'' In addition to its license arrangement with Textron Automotive, BCAM International has strategic alliances with: -- Reebok International Inc. has an exclusive license to incorporate IST into sports, fitness and casual footwear; -- Sealy Inc., a leading maker of bedding and mattress products, has an option to use IST in the bedding field; BCAM International Inc., Melville, New York, specializes in the development of technology that enables surfaces touching the body, including in seating, footwear and mattresses, to automatically to adjust themselves in real time to conform to any part of the body for utmost of comfort, fit and enhanced user performance. The Company is also engaged in the consolidation of the highly fragmented medical footcare industry. This announcement contains ''forward-looking'' statements. The words, ''anticipate,'' ''believe,'' ''estimate,'' and ''expect'' and other similar expressions as they relate to the Company and its management are intended to identify such forward-looking statements. Although the Company and its management believe that the statements contained in this announcement are reasonable, it can give no assurances that such statements will prove correct. Factors that could affect the occurrence of events or results discussed herein include those mentioned in the Company's Form 10-KSB.